The Graft

ALL EPISODES AS VIDEO

FOLLOW MLL

FOLLOW Daniela Twitter: @HermelinMD https://www.bloodcenter.org/about/news/authors/daniela-hermelin-md-a7/ https://www.blooducation.com/about-dr-hermelin ALL EPISODES AS AUDIO  APPLE https://podcasts.apple.com/de/podcast/the-graft/id1543609846   SPOTIFY https://open.spotify.com/show/2x2ovFm0cG0NmgyItygbab  GOOGLE https://podcasts.google.com/feed/aHR0cHM6Ly9hbmNob3IuZm0vcy80Mjk1MzA1Yy9wb2RjYXN0L3Jzcw== CONNECT WITH US https://twitter.com/TheEBMT_Trainee  https://www.ebmt.org/trainee-committee  https://twitter.com/NicoGagelmann  https://twitter.com/Claire_P_Horgan

https://twitter.com/AbbasiMuqtadir

 CONNECT WITH US 

https://twitter.com/TheEBMT_Trainee  

https://www.ebmt.org/trainee-committee  

https://twitter.com/NicoGagelmann  

https://twitter.com/Claire_P_Horgan

Dr. Brudno researches the use of chimeric antigen receptor (CAR) T-cell  therapy to treat cancers of the blood, including Non-Hodgkin lymphoma,  Hodgkin lymphoma, acute lymphoblastic leukemia (ALL), and multiple  myeloma. Her focus is in the development of phase I clinical trials. She  is also interested in patient safety, particularly in optimizing  patient safety for cellular immunotherapies.

Nico Gagelmann and Jennifer Brudno

ALL EPISODES AS AUDIO 

APPLE https://podcasts.apple.com/de/podcast/the-graft/id1543609846  

SPOTIFY https://open.spotify.com/show/2x2ovFm0cG0NmgyItygbab 

GOOGLE https://podcasts.google.com/feed/aHR0cHM6Ly9hbmNob3IuZm0vcy80Mjk1MzA1Yy9wb2RjYXN0L3Jzcw==

CONNECT WITH US

https://twitter.com/TheEBMT_Trainee 

https://www.ebmt.org/trainee-committee 

https://twitter.com/NicoGagelmann 

https://twitter.com/Claire_P_Horgan

Heslop is a professor of medicine and pediatrics and holds the Dan L  Duncan Chair at Baylor. She is a physician-scientist engaged in  translational research focusing on adoptive immunotherapy with  gene-modified effector cells to improve hemopoietic stem cell  transplantation and cancer therapy. She has extensive experience in  developing and conducting transplant studies and cell and gene therapy  studies and currently holds more than 20 Investigational New Drug  Applications. She also has played a major role nationally as president  of societies focusing on the intellectual and clinical development of  cellular therapies and accreditation of facilities delivering cell  therapies. Dr. Helen Heslop has been elected to the National Academy of  Medicine. She is among 90 regular members and 10 international members  announced today at the Academy’s annual meeting.

Dr. Mohyuddin completed his medical training at Aga Khan University in  Pakistan and his internal medicine residency at the University of Kansas  where he developed a passion for medical education and treating  hematological malignancies. He completed his fellowship developing a  clinical and research interest in multiple myeloma, drug repurposing,  quality of scientific methods end of life, cost-effective/evidence based  care and medical education. He enjoys the outdoors, and that drew him  to life in Utah where he is currently Assistant Professor at the  Huntsman Cancer Institute with a focus on multiple myeloma.

Nikita Mehra (@DrNikitaMehra) is an Associate Professor at Medical  Oncology and Researcher in Molecular Oncology in the Cancer Institute  (WIA), Chennai, India.

Dr. Raffaella Greco (@RaffaellaGrecoM) is a hematologist in the  Department of Hematology and Bone Marrow Transplantation at the IRCCS  Ospedale San Raffaele under the supervision of Professor Fabio Ciceri. After graduating in 2008 from the Faculty of Medicine and Surgery of the  University of Milan Vita-Salute San Raffaele received a specialization  in hematology at the same university in 2014.

CONNECT WITH US 

https://twitter.com/TheEBMT_Trainee 

https://www.ebmt.org/trainee-committee 

https://twitter.com/NicoGagelmann 

https://twitter.com/Claire_P_Horgan